Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-25-104626
Filing Date
2025-08-07
Accepted
2025-08-07 09:07:10
Documents
73
Period of Report
2025-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q nuvb-20250630.htm   iXBRL 10-Q 3342233
2 EX-10.1 nuvb-ex10_1.htm EX-10.1 28081
3 EX-31.1 nuvb-ex31_1.htm EX-31.1 17875
4 EX-31.2 nuvb-ex31_2.htm EX-31.2 17965
5 EX-32.1 nuvb-ex32_1.htm EX-32.1 9524
6 EX-32.2 nuvb-ex32_2.htm EX-32.2 8286
  Complete submission text file 0000950170-25-104626.txt   12136933

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT nuvb-20250630.xsd EX-101.SCH 1433510
76 EXTRACTED XBRL INSTANCE DOCUMENT nuvb-20250630_htm.xml XML 2341010
Mailing Address 357 TEHAMA STREET, FLOOR 3 SAN FRANCISCO CA 94103
Business Address 357 TEHAMA STREET, FLOOR 3 SAN FRANCISCO CA 94103 (415) 754-3517
Nuvation Bio Inc. (Filer) CIK: 0001811063 (see all company filings)

EIN.: 850862255 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39351 | Film No.: 251191979
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)